AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
Log in

NASDAQ:MDGLMadrigal Pharmaceuticals News Headlines

$119.58
-6.13 (-4.88 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$119.50
Now: $119.58
$127.25
50-Day Range
$60.13
MA: $91.73
$125.71
52-Week Range
$56.82
Now: $119.58
$127.25
Volume160,219 shs
Average Volume206,885 shs
Market Capitalization$1.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.19

Headlines

Madrigal Pharmaceuticals (NASDAQ MDGL) News Headlines

Source:
DateHeadline
B. Riley Raises Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $174.00B. Riley Raises Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $174.00
www.americanbankingnews.com - May 22 at 8:17 AM
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Short Interest UpdateMadrigal Pharmaceuticals Inc (NASDAQ:MDGL) Short Interest Update
www.americanbankingnews.com - May 15 at 6:36 AM
Madrigal Pharmaceuticals Inc Expected to Post Q2 2020 Earnings of ($2.47) Per Share (NASDAQ:MDGL)Madrigal Pharmaceuticals Inc Expected to Post Q2 2020 Earnings of ($2.47) Per Share (NASDAQ:MDGL)
www.americanbankingnews.com - May 14 at 9:55 AM
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Receives Average Recommendation of "Buy" from AnalystsMadrigal Pharmaceuticals Inc (NASDAQ:MDGL) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 13 at 2:54 AM
Madrigal Pharmaceuticals (NASDAQ:MDGL) Releases Quarterly  Earnings Results, Misses Estimates By $0.40 EPSMadrigal Pharmaceuticals (NASDAQ:MDGL) Releases Quarterly Earnings Results, Misses Estimates By $0.40 EPS
www.americanbankingnews.com - May 10 at 8:50 PM
Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)?Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)?
finance.yahoo.com - May 10 at 3:40 PM
 Analysts Expect Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) to Post -$2.09 EPS Analysts Expect Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) to Post -$2.09 EPS
www.americanbankingnews.com - May 10 at 12:30 PM
Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $168.00 by Analysts at HC WainwrightMadrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $168.00 by Analysts at HC Wainwright
www.americanbankingnews.com - May 8 at 11:25 PM
Madrigal Pharmaceuticals (NASDAQ:MDGL) Receives "Hold" Rating from Stifel NicolausMadrigal Pharmaceuticals (NASDAQ:MDGL) Receives "Hold" Rating from Stifel Nicolaus
www.americanbankingnews.com - May 8 at 6:22 AM
Madrigal Pharmaceuticals EPS misses by $0.40Madrigal Pharmaceuticals EPS misses by $0.40
seekingalpha.com - May 7 at 4:42 PM
Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and HighlightsMadrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights
finance.yahoo.com - May 7 at 4:42 PM
Chardan Capital Begins Coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL)Chardan Capital Begins Coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL)
www.americanbankingnews.com - May 5 at 8:17 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Madrigal Pharmaceuticals, Inc. - MDGLSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Madrigal Pharmaceuticals, Inc. - MDGL
finance.yahoo.com - May 5 at 6:01 PM
Barclays issues flurry of healthcare ratings in premarket analyst actionBarclays issues flurry of healthcare ratings in premarket analyst action
seekingalpha.com - May 5 at 8:08 AM
Madrigals Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaMadrigal's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - April 19 at 7:26 AM
Madrigal Pharmaceuticals Inc.Madrigal Pharmaceuticals Inc.
www.barrons.com - April 18 at 7:55 PM
Noteworthy Tuesday Option Activity: MDGL, DKS, EXPENoteworthy Tuesday Option Activity: MDGL, DKS, EXPE
www.nasdaq.com - April 14 at 7:35 PM
Madrigal Pharma up 13% on positive data on NASH drug resmetiromMadrigal Pharma up 13% on positive data on NASH drug resmetirom
seekingalpha.com - April 14 at 9:34 AM
Madrigal MAESTRO Phase 3 NASH Trials Continue without Protocol Modifications; New Data Demonstrate that Reductions in Liver Fat Achieved by Resmetirom Predict NASH Resolution and Fibrosis ReductionMadrigal MAESTRO Phase 3 NASH Trials Continue without Protocol Modifications; New Data Demonstrate that Reductions in Liver Fat Achieved by Resmetirom Predict NASH Resolution and Fibrosis Reduction
finance.yahoo.com - April 14 at 9:34 AM
Madrigal: A Stellar Stock For This Coronavirus Bear MarketMadrigal: A Stellar Stock For This Coronavirus Bear Market
seekingalpha.com - April 7 at 3:20 PM
Madrigal Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results and HighlightsMadrigal Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights
finance.yahoo.com - February 26 at 8:16 AM
Doubling Down On Madrigal PharmaceuticalsDoubling Down On Madrigal Pharmaceuticals
seekingalpha.com - February 5 at 1:10 AM
Why Madrigal Pharma Stock Could Still Double From NASH DevelopmentWhy Madrigal Pharma Stock Could Still Double From NASH Development
247wallst.com - January 30 at 12:12 PM
Madrigal Pharmaceuticals, Inc. (MDGL): Hedge Fund Sentiment UnchangedMadrigal Pharmaceuticals, Inc. (MDGL): Hedge Fund Sentiment Unchanged
finance.yahoo.com - December 19 at 10:56 PM
Dosing underway in Madrigals late-stage resmetirom studyDosing underway in Madrigal's late-stage resmetirom study
seekingalpha.com - December 18 at 8:55 AM
Madrigal Pharmaceuticals Announces First Patient Dosed in MAESTRO-NAFLD-1, a Second Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Resmetirom (MGL-3196) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Presumed NASH (NASH/NAFLD (non-alcoholic fatty liver disease))Madrigal Pharmaceuticals Announces First Patient Dosed in MAESTRO-NAFLD-1, a Second Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Resmetirom (MGL-3196) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Presumed NASH (NASH/NAFLD (non-alcoholic fatty liver disease))
finance.yahoo.com - December 18 at 8:55 AM
Madrigal Pharmaceuticals investor selling large chunk of its stakeMadrigal Pharmaceuticals investor selling large chunk of its stake
finance.yahoo.com - December 13 at 8:36 AM
Notable Two Hundred Day Moving Average Cross - MDGLNotable Two Hundred Day Moving Average Cross - MDGL
www.nasdaq.com - December 11 at 1:14 PM
Madrigal Pharmaceuticals prices 1.2M-share offeringMadrigal Pharmaceuticals prices 1.2M-share offering
seekingalpha.com - December 11 at 8:14 AM
Madrigal Pharmaceuticals Announces Pricing of Secondary OfferingMadrigal Pharmaceuticals Announces Pricing of Secondary Offering
finance.yahoo.com - December 11 at 12:27 AM
Madrigal launches 1.2M-share stock offering by current investorMadrigal launches 1.2M-share stock offering by current investor
seekingalpha.com - December 10 at 7:27 PM
Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common StockMadrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock
www.marketwatch.com - December 10 at 7:27 PM
Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common StockMadrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock
finance.yahoo.com - December 10 at 7:27 PM
NASH Scorecard Year to Date: The Winners and the LosersNASH Scorecard Year to Date: The Winners and the Losers
finance.yahoo.com - November 29 at 12:18 PM
Madrigal Pharmaceuticals Announces Publication in The Lancet of Positive Phase 2 Results for Resmetirom (MGL-3196) for the Treatment of Non-alcoholic Steatohepatitis (NASH)Madrigal Pharmaceuticals Announces Publication in The Lancet of Positive Phase 2 Results for Resmetirom (MGL-3196) for the Treatment of Non-alcoholic Steatohepatitis (NASH)
finance.yahoo.com - November 11 at 5:54 PM
Madrigal Pharmaceuticals (MDGL) Shares Cross Above 200 DMAMadrigal Pharmaceuticals (MDGL) Shares Cross Above 200 DMA
www.nasdaq.com - November 11 at 12:54 PM
Madrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and HighlightsMadrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and Highlights
finance.yahoo.com - November 6 at 7:48 AM
Hedge Funds Are Dumping Madrigal Pharmaceuticals, Inc. (MDGL)Hedge Funds Are Dumping Madrigal Pharmaceuticals, Inc. (MDGL)
finance.yahoo.com - October 26 at 5:49 PM
MDGL.O - Madrigal Pharmaceuticals Inc Profile | ReutersMDGL.O - Madrigal Pharmaceuticals Inc Profile | Reuters
www.reuters.com - October 6 at 7:33 PM
Madrigal: A Basic OverviewMadrigal: A Basic Overview
seekingalpha.com - September 26 at 4:16 PM
What Kind Of Share Price Volatility Should You Expect For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)?What Kind Of Share Price Volatility Should You Expect For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)?
finance.yahoo.com - September 19 at 8:24 PM
Potential Winner Of The First NASH BattlePotential Winner Of The First NASH Battle
seekingalpha.com - September 10 at 5:54 AM
BRIEF-Madrigal Pharmaceuticals Reports 2019 Q2 Loss Per Share $1.28BRIEF-Madrigal Pharmaceuticals Reports 2019 Q2 Loss Per Share $1.28
www.msn.com - August 7 at 9:58 PM
Madrigal Pharmaceuticals Reports 2019 Second Quarter Financial Results and HighlightsMadrigal Pharmaceuticals Reports 2019 Second Quarter Financial Results and Highlights
finance.yahoo.com - August 7 at 11:08 AM
Madrigal: Weighed Down By Relevant Concerns Heading Into Pivotal DataMadrigal: Weighed Down By Relevant Concerns Heading Into Pivotal Data
seekingalpha.com - July 31 at 10:46 PM
New President of R&D at Madrigal PharmaNew President of R&D at Madrigal Pharma
seekingalpha.com - July 11 at 8:42 AM
Madrigal Pharmaceuticals Promotes Rebecca Taub, M.D., Chief Medical Officer and Executive Vice President of Research & Development, to Newly Created Position of President of Research & DevelopmentMadrigal Pharmaceuticals Promotes Rebecca Taub, M.D., Chief Medical Officer and Executive Vice President of Research & Development, to Newly Created Position of President of Research & Development
finance.yahoo.com - July 11 at 8:42 AM
Have Insiders Been Buying Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares?Have Insiders Been Buying Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares?
finance.yahoo.com - July 10 at 6:25 PM
Here’s What Hedge Funds Think About Madrigal Pharmaceuticals, Inc. (MDGL)Here’s What Hedge Funds Think About Madrigal Pharmaceuticals, Inc. (MDGL)
finance.yahoo.com - June 20 at 12:21 AM
Madrigal Pharmaceuticals to Present at Upcoming Investment ConferencesMadrigal Pharmaceuticals to Present at Upcoming Investment Conferences
finance.yahoo.com - June 4 at 8:51 AM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.